Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11494146rdf:typepubmed:Citationlld:pubmed
pubmed-article:11494146lifeskim:mentionsumls-concept:C0205169lld:lifeskim
pubmed-article:11494146lifeskim:mentionsumls-concept:C1517342lld:lifeskim
pubmed-article:11494146lifeskim:mentionsumls-concept:C1366450lld:lifeskim
pubmed-article:11494146lifeskim:mentionsumls-concept:C1512424lld:lifeskim
pubmed-article:11494146lifeskim:mentionsumls-concept:C0741847lld:lifeskim
pubmed-article:11494146lifeskim:mentionsumls-concept:C0181586lld:lifeskim
pubmed-article:11494146pubmed:issue33lld:pubmed
pubmed-article:11494146pubmed:dateCreated2001-8-8lld:pubmed
pubmed-article:11494146pubmed:abstractTextThe pro-apoptotic molecule BAD binds BCL-[X(L)] or BCL2 and inactivates their survival function. In addition to their anti-apoptotic function, BCL2 and BCL-[X(L)] also delay cell cycle entry from quiescence. We found that the BH3-only molecule BAD also exerted a cell cycle effect. BAD expression resulted in failure to cell cycle block in growth arrest conditions. In low serum and in confluence, fibroblasts constitutively or inducibly expressing BAD persisted in S phase, continued to incorporate BrdU, and exhibited sustained cyclin E/cdk2 activity. Mutation analysis indicated that the cell cycle effect of BAD was not dependent on its phosphorylation status or subcellular localization, but strictly co-segregated with BCL-[X(L)] binding. bclx(-/-) MEFs expressing BAD and bad(-/-) MEFs both arrested in G0/G1 in low serum similar to wild-type controls, suggesting that the ability to overcome the G0/G1 checkpoint resulted from the presence of BAD/BCL-x(L) heterodimers, rather than the absence of BCL-[X(L)] or BAD. These data provide evidence that in addition to regulating apoptosis, the BAD/BCL-[X(L)] heterodimer has a novel cell cycle function.lld:pubmed
pubmed-article:11494146pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:languageenglld:pubmed
pubmed-article:11494146pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:citationSubsetIMlld:pubmed
pubmed-article:11494146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494146pubmed:statusMEDLINElld:pubmed
pubmed-article:11494146pubmed:monthJullld:pubmed
pubmed-article:11494146pubmed:issn0950-9232lld:pubmed
pubmed-article:11494146pubmed:authorpubmed-author:YanoMMlld:pubmed
pubmed-article:11494146pubmed:authorpubmed-author:Chattopadhyay...lld:pubmed
pubmed-article:11494146pubmed:authorpubmed-author:ChiangC WCWlld:pubmed
pubmed-article:11494146pubmed:issnTypePrintlld:pubmed
pubmed-article:11494146pubmed:day27lld:pubmed
pubmed-article:11494146pubmed:volume20lld:pubmed
pubmed-article:11494146pubmed:ownerNLMlld:pubmed
pubmed-article:11494146pubmed:authorsCompleteYlld:pubmed
pubmed-article:11494146pubmed:pagination4507-18lld:pubmed
pubmed-article:11494146pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:meshHeadingpubmed-meshheading:11494146...lld:pubmed
pubmed-article:11494146pubmed:year2001lld:pubmed
pubmed-article:11494146pubmed:articleTitleBAD/BCL-[X(L)] heterodimerization leads to bypass of G0/G1 arrest.lld:pubmed
pubmed-article:11494146pubmed:affiliationDepartment of Pediatrics, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.lld:pubmed
pubmed-article:11494146pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11494146pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11494146pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:572entrezgene:pubmedpubmed-article:11494146lld:entrezgene
entrez-gene:598entrezgene:pubmedpubmed-article:11494146lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11494146lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11494146lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11494146lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11494146lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11494146lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11494146lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11494146lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11494146lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11494146lld:pubmed